Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

eurocept international b.v. - morphinhydrochloridtrihydrat - injektionsvæske, opløsning - 10 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

eurocept international b.v. - amsacrin - pulver til koncentrat til infusionsvæske, opløsning - 75 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

eurocept international b.v. - morphinhydrochloridtrihydrat - infusionsvæske, opløsning - 1 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

eurocept international b.v. - ketaminhydrochlorid - injektionsvæske, opløsning - 10 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

eurocept international b.v. - morphinhydrochloridtrihydrat - injektionsvæske, opløsning - 1 mg/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmathen international s.a. - pramipexol - tabletter - 0,088 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmathen international s.a. - travoprost - øjendråber, opløsning - 30 mikrogram/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

janssen-cilag international n.v.    - amivantamab - carcinom, ikke-småcellet lunge - antineoplastiske midler - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

pharmascience international ltd. - cinacalcethydrochlorid - filmovertrukne tabletter - 30 mg